Search results
Results from the WOW.Com Content Network
It primarily covers crop protection and seeds for farmers. Syngenta is part of the Syngenta Group, entirely owned by Sinochem, a Chinese state-owned enterprise. [2] Syngenta was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca, and acquired by China National Chemical Corporation (ChemChina) in 2017. [3]
In September 2012, Syngenta placed a bid of 403 million euros ($522 million) for the acquisition of Devgen as part of a wave of large ag companies buying biotech companies. [ 22 ] [ 23 ] The offer came six months after the companies had signed an agreement under which Syngenta would have developed sprayable RNAi-based crop protection products ...
The release of transgenic crops in India is governed by the Indian Environment Protection Act, which was enacted in 1986. The Institutional Biosafety Committee (IBSC), Review Committee on Genetic Manipulation (RCGM) and Genetic Engineering Approval Committee (GEAC) all review any genetically modified organism to be released, with transgenic crops also needing permission from the Ministry of ...
Northrup-King Seed Company was founded in Minneapolis, Minnesota in 1896, and was based there until it was acquired and moved to Golden Valley, Minnesota in 1986. It is now a division of Syngenta . Company history
In 2014 the global value of biotech seed was US$15.7 billion; US$11.3 billion (72%) was in industrial countries and US$4.4 billion (28%) was in the developing countries. [89] In 2009, Monsanto had $7.3 billion in sales of seeds and from licensing its technology; DuPont, through its Pioneer subsidiary, was the next biggest company in that market ...
1924 - Henry Wallace begins selling 'Copper Cross', an early commercial hybrid seed corn. 1926 - Hi-Bred Corn Company is founded in Des Moines, Iowa, with $7,000 in capital. [7] 1931 - Roswell Garst agrees to produce/distribute seed. The following year Garst partners with Charles Thomas to form the Garst and Thomas Seed Corn Company.
Thiamethoxam was developed by Ciba-Geigy (now Syngenta) in 1991 [9] and launched in 1998; [10] a patent dispute arose with Bayer which already had patents covering other neonicotinoids including imidacloprid and clothianidin. In 2002 the dispute was settled, with Syngenta paying Bayer $120 million in exchange for worldwide rights to ...
A 2014 review found that the performance of animals fed GM feed was similar to that of animals fed "isogenic non-GE crop lines". [192] A 2012 review of 12 long-term studies and 12 multigenerational studies conducted by public research laboratories concluded that none had discovered any safety problems linked to consumption of GM food. [193]